Update on Hepatitis C treatment: Systematic review of clinical trials.

Update on Hepatitis C treatment: Systematic review of clinical trials.
Minerva Gastroenterol Dietol. 2016 Oct 21;
Authors: Jhaveri M, Procaccini N, Kowdley KV
Abstract
Chronic Hepatitis C is a major public health problem. The chronicity of the Hepatitis C can lead to advanced liver disease, cirrhosis and even hepatocellular carcinoma. Chronic hepatitis C is the leading indication of for liver transplantation in the United States. Since the introduction of directly acting antiviral agents (DAAs), there have been there have been dramatic advances in treatment of hepatitis C in terms of tolerability, duration of therapy with significant increases in the rates of sustained virology response (SVR). This review summarizes the findings of recently published clinical trials of DAAs in the treatment of hepatitis C by genotype and in patients co-infected with HCV / HIV.
PMID: 27768010 [PubMed - as supplied by publisher]

Source: Minerva Gastroenterologica e Dietologica - October 23, 2016 Category: Gastroenterology Tags: Minerva Gastroenterol Dietol Source Type: research